NASDAQ:OTLK

Outlook Therapeutics Stock Predictions

etoro logo Buy OTLK
*Your capital is at risk
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

OTLK Prediction Chart

OTLK Predictions History

Latest community submissions for OTLK.
Predictor Target Session Target Price Result Direction Accuracy Score
May 19, 2026 $0.220 -4.00% $0.228 V 96.34% 1
May 19, 2026 $0.240 +4.76% $0.228 X 94.87% 0
May 19, 2026 $0.236 +2.98% $0.228 X 96.66% 0
May 19, 2026 Bearish $0.228 X 1
May 5, 2026 $0.252 -4.00% $0.242 V 95.74% 1
May 5, 2026 $0.248 -5.40% $0.242 V 97.26% 1
May 5, 2026 $0.271 +3.37% $0.242 X 87.73% 0
May 5, 2026 $3.00 +1 042.86% Unrealistic Excluded from avg $0.242 X 0.00% 0
Apr 2, 2026 $0.195 -7.31% $0.219 X 88.88% 0
Apr 2, 2026 $0.200 -4.57% $0.219 X 91.51% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for OTLK with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE